Literature DB >> 1347616

Drug interactions in use of dapsone for Pneumocystis carinii prophylaxis.

H W Horowitz, U P Jorde, G P Wormser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1347616     DOI： 10.1016/0140-6736(92)90649-n

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients.

Authors:  R Heylen; R Miller
Journal:  Genitourin Med       Date:  1996-08

Review 2.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Drug interactions with antiviral drugs.

Authors:  A M Taburet; E Singlas
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

Review 4.  Pharmacokinetic interactions with rifampicin : clinical relevance.

Authors:  Mikko Niemi; Janne T Backman; Martin F Fromm; Pertti J Neuvonen; Kari T Kivistö
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  Evaluation of effects of altered gastric pH on absorption of dapsone in healthy volunteers.

Authors:  G A Breen; J M Brocavich; J V Etzel; V Shah; P Schaefer; S Forlenza
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

Review 6.  Pharmacokinetic drug interactions with antimicrobial agents.

Authors:  J G Gillum; D S Israel; R E Polk
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

Review 7.  Tuberculosis and pharmacological interactions: A narrative review.

Authors:  Niccolò Riccardi; Diana Canetti; Paola Rodari; Giorgio Besozzi; Laura Saderi; Marco Dettori; Luigi R Codecasa; Giovanni Sotgiu
Journal:  Curr Res Pharmacol Drug Discov       Date:  2020-12-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.